|
|
Previous Article | Table of Contents | Next Article 
Identification and analysis of human erythropoietin receptors on a
factor-dependent cell line, TF-1
T Kitamura, A Tojo, T Kuwaki, S Chiba, K Miyazono, A Urabe and F Takaku
Third Department of Internal Medicine, Faculty of Medicine, University of
Tokyo, Japan.
We have recently established a novel cell line, TF-1, from bone marrow
cells of a patient with erythroleukemia, that showed an absolute growth
dependency on each of three hematopoietic growth factors: erythropoietin
(EPO) granulocyte-macrophage colony-stimulating factor (GM-CSF), and
interleukin 3 (IL-3). EPO stimulated the proliferation of TF-1 cells even
at the physiologic concentration (0.03 U/mL). We performed binding
experiments on TF-1 cells using radioiodinated EPO. The binding of
radioiodinated EPO to TF-1 was specific, time- and temperature-dependent,
and saturable. Scatchard analysis of the saturation binding data suggested
the existence of a single class of binding sites (kd = 0.40 nmol/L; number
of binding sites = 1,630 per cell). TF-1 cells were usually maintained in
RPMI 1640 containing 10% fetal bovine serum and 5 ng/mL GM-CSF. The kd and
the number of the EPO receptors were not changed by incubating the cells
with IL-3, although culturing the cells in the presence of EPO resulted in
down-modulation of EPO receptors. The chemical cross-linking study
demonstrated that two molecules with apparent molecular weights of 105
kilodalton (Kd) and 90 Kd were the binding components of EPO. Present data
suggest that human EPO receptors are very similar to the previously
reported murine EPO receptors.
Volume 73,
Issue 2,
pp. 375-380,
02/01/1989
Copyright © 1989 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kioi, S. Seetharam, and R. K. Puri
N-linked glycosylation of IL-13R{alpha}2 is essential for optimal IL-13 inhibitory activity
FASEB J,
November 1, 2006;
20(13):
2378 - 2380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Korzenik, B. K. Dieckgraefe, J. F. Valentine, D. F. Hausman, M. J. Gilbert, and the Sargramostim in Crohn's Disease Study Group
Sargramostim for Active Crohn's Disease
N. Engl. J. Med.,
May 26, 2005;
352(21):
2193 - 2201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Abdel-Mageed, F. Zhao, B. J. Rider, and K. C. Agrawal
Erythropoietin-Induced Metallothionein Gene Expression: Role in Proliferation of K562 Cells
Experimental Biology and Medicine,
October 1, 2003;
228(9):
1033 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cermak, S. Simova, A. Pintzas, V. Horejsi, and L. Andera
Molecular Mechanisms Involved in CD43-mediated Apoptosis of TF-1 Cells. ROLES OF TRANSCRIPTION, Daxx EXPRESSION, AND ADHESION MOLECULES
J. Biol. Chem.,
March 1, 2002;
277(10):
7955 - 7961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bovolenta, E. Pilotti, M. Mauri, M. Turci, P. Ciancianaini, P. Fisicaro, U. Bertazzoni, G. Poli, and C. Casoli
Human T-cell leukemia virus type 2 induces survival and proliferation of CD34+ TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor
Blood,
January 1, 2002;
99(1):
224 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Oshima, B. H. Joshi, and R. K. Puri
Conversion of Interleukin-13 into a High Affinity Agonist by a Single Amino Acid Substitution
J. Biol. Chem.,
May 5, 2000;
275(19):
14375 - 14380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M.L. Tuyt, K. Bregman, C. Lummen, W. H.A. Dokter, and E. Vellenga
Differential Binding Activity of the Transcription Factor LIL-Stat in Immature and Differentiated Normal and Leukemic Myeloid Cells
Blood,
August 15, 1998;
92(4):
1364 - 1373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. L. Rock, G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan
A family of human receptors structurally related to Drosophila Toll
PNAS,
January 20, 1998;
95(2):
588 - 593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. de Jong, Y. Westerman, G. Wagemaker, and A. W. Wognum
Coexpression of Kit and the Receptors for Erythropoietin, Interleukin 6 and GM-CSF on Hemopoietic Cells
Stem Cells,
July 1, 1997;
15(4):
275 - 285.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. J. Taxman and D. M. Wojchowski
Erythropoietin-induced Transcription at the Murine beta[IMAGE]-Globin Promoter
J. Biol. Chem.,
March 24, 1995;
270(12):
6619 - 6627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guillard, S. Chretien, R. Jockers, S. Fichelson, P. Mayeux, and V. Duprez
Coupling of Heterotrimeric Gi Proteins to the Erythropoietin Receptor
J. Biol. Chem.,
January 12, 2001;
276(3):
2007 - 2014.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|